Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype.
about
Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancerProteomic discovery of genistein action in the rat mammary glandRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessUp-regulation of multiple proteins and biological processes during maxillary expansion in ratsSpermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.AN INTEGRATIVE ANALYSIS OF CANCER GENE EXPRESSION STUDIES USING BAYESIAN LATENT FACTOR MODELING.Screening of multiple myeloma by polyclonal rabbit anti-human plasmacytoma cell immunoglobulin.Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancerTerazosin activates Pgk1 and Hsp90 to promote stress resistanceEpigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasionAnticancer agents that counteract tumor glycolysis.Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.Protein profiles associated with survival in lung adenocarcinoma4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studiesSub-emetic toxicity of Bacillus cereus toxin cereulide on cultured human enterocyte-like Caco-2 cells.
P2860
Q28255495-B7091449-6B19-4ED0-8B9E-D1EE3B264E3CQ28569586-DDFCF839-5BEF-4162-B8CE-67FF1D489A15Q30446460-E62E9557-8C23-4AB9-9375-9CC788D604A6Q33250633-21748B69-B354-4C70-B30F-64762A047E05Q33325686-FF5A40BD-190F-4D5C-B7E3-44189B0B9A2EQ33424526-601549F6-FA7A-48FC-91B3-79D9055633BAQ34196222-B7702D53-9F5A-4A4C-A7CD-98216315BA71Q34656161-5F6137BB-F426-4240-94EA-7AE8B79BDD99Q35475373-922E27D0-93A7-46F2-B8AD-C94E2301985DQ35545874-27ED5140-3047-46FD-88B6-F662AABB3D74Q36187865-7F95A1A3-F200-4694-AAD4-5EB2E41457D7Q36452381-7C7111F6-5C78-4705-9E32-2E6AEE367606Q36955828-42C071D9-CC7C-47BE-8800-F486262D021BQ37003211-14A5269C-43AE-4489-AA7D-99DA9AA0BD26Q37089504-D9010E98-513B-4350-BB88-AD0683211013Q37960537-90ACCD66-7916-4306-BC97-A802BB08376FQ38968626-CD4577A6-591B-4189-BC13-342D15992BCC
P2860
Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Overexpression of human phosph ...... ultidrug resistance phenotype.
@ast
Overexpression of human phosph ...... ultidrug resistance phenotype.
@en
type
label
Overexpression of human phosph ...... ultidrug resistance phenotype.
@ast
Overexpression of human phosph ...... ultidrug resistance phenotype.
@en
prefLabel
Overexpression of human phosph ...... ultidrug resistance phenotype.
@ast
Overexpression of human phosph ...... ultidrug resistance phenotype.
@en
P2093
P1433
P1476
Overexpression of human phosph ...... ultidrug resistance phenotype.
@en
P2093
P304
P407
P577
2002-07-01T00:00:00Z